2019 - Ongoing
Advocacy for the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) project
MMGH is part of the Vaccine Against Invasive non-typhoidal Salmonella (Vacc-iNTS) consortium, made up of 12 partners from eight different countries including three disease-endemic countries. The initiative advances the development of an iNTS vaccine by conducting a Phase I clinical study in Europe and Africa. The project, funded by the European Union’s Horizon 2020 Research and Innovation Programme, will investigate the immunogenicity and safety of a iNTS-GMMA vaccine. As part of this effort MMGH will focus on strengthening a collaborative network to enhance disease awareness and drive vaccine advocacy.